Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21868464 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Interventions: Drug: Sugammadex;   Drug: Neostigmine
2 Recruiting The Association of CPAP Compliance Study
Condition: Obstructive Sleep Apnea
Intervention:

Study has passed its completion date and status has not been verified in more than two years.